A new gene therapy could revolutionize the treatment of dise

A new gene therapy could revolutionize the treatment of diseases like sickle cell anaemia. Here's how

The UK is the first to approve a CRISPR-based gene therapy for treating sickle cell disease and beta thalassemia. But not everyone is likely to get access.

Related Keywords

United Kingdom , Jennifer Doudna , Emmanuelle Charpentier , World Economic Forum Global Health , Forum Agenda , Middle Eastern , World Economic Forum , Global Health , Healthcare Strategic Outlook , Senior Writer ,